| Announced on | Meeting on |
| May 21, 2024 | May 29, 2024 |
| Audited Results | |
| Jan 31, 2024 | Feb 12, 2024 |
| Quarterly Results | |
| Oct 26, 2023 | Nov 08, 2023 |
| Quarterly Results | |
| Jul 31, 2023 | Aug 10, 2023 |
| Quarterly Results | |
| May 15, 2023 | May 29, 2023 |
| Audited Results & Final Dividend | |
Titan Biotech Share Price
BSE
- OpenN.A.
- HighN.A.
- LowN.A.
- Prev CloseN.A.
- VolumeN.A.
- VWAP(₹)N.A.
Titan Biotech share price insights
Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 13.62% outperformed its 3 year CAGR of 5.0%. (Source: Consolidated Financials)Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 75.29% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 14.45% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)Titan Biotech Share Price Update
Titan Biotech Ltd. share price moved up by 1.42% from its previous close of Rs 602.30. Titan Biotech Ltd. stock last traded price is 610.90
Share Price Value Today/Current/Last 610.90 Previous Day 602.30
Titan Biotech Share Price Returns
| 1 Day | 1.42% |
| 1 Month | 12.93% |
| 3 Months | 15.2% |
| 1 Year | 131.18% |
| 3 Years | 77.95% |
| 5 Years | 1529.07% |
Key Metrics
| PE Ratio(x) | 20.31 |
| EPS - TTM(₹) | 30.07 |
| MCap(₹ Cr.) | 504.83 |
| MCap Rank | 89 |
| PB Ratio(x) | 3.74 |
| Div Yield(%) | 0.33 |
| Face Value(₹) | 10.00 |
| 52W High(₹) | 645.00 |
| 52W Low(₹) | 250.25 |
| MCap/Sales | 2.66 |
| Beta(1 Month) | -0.20 |
| BV/Share(₹) | 161.49 |
Titan Biotech Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
ADVERTISEMENT
Titan Biotech News & Analysis
ADVERTISEMENT
Titan Biotech Financials
Consolidated
Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Total Income 40.40 46.42 43.98 35.03 37.33 Total Income Growth (%) -12.97 5.54 25.55 -6.16 21.94 Total Expenses 33.68 36.21 35.57 27.66 30.72 Total Expenses Growth (%) -6.99 1.79 28.63 -9.96 14.43 EBIT 6.72 10.20 8.41 7.37 6.61 EBIT Growth (%) -34.19 21.39 14.00 11.49 75.41 Profit after Tax (PAT) 5.00 7.17 6.52 6.16 4.95 PAT Growth (%) -30.36 10.02 5.86 24.43 51.80 EBIT Margin (%) 16.62 21.98 19.11 21.05 17.72 Net Profit Margin (%) 12.37 15.46 14.83 17.59 13.26 Basic EPS (₹) 5.86 8.68 7.89 7.47 6.07 All figures in Rs Cr, unless mentioned otherwise
InsightsBeating 3 Yr Revenue CAGR
Company's annual revenue growth of 13.62% outperformed its 3 year CAGR of 5.0%. (Source: Consolidated Financials)Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 14.45% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 156.58 134.52 143.40 100.72 76.04 Total Assets Growth (%) 16.40 -6.20 42.38 32.45 17.47 Total Liabilities 23.13 24.60 37.99 28.24 34.49 Total Liabilities Growth (%) -6.00 -35.23 34.51 -18.13 11.37 Total Equity 133.45 109.91 105.41 72.48 41.55 Total Equity Growth (%) 21.42 4.27 45.44 74.45 23.07 Current Ratio (x) 3.77 3.36 3.62 3.10 2.16 Total Debt to Equity (x) 0.05 0.06 0.16 0.19 0.58 Contingent Liabilities 0.00 1.13 3.20 0.38 - All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities 21.15 21.18 22.86 19.24 6.12 Net Cash used in Investing Activities -20.30 -20.73 -18.78 -8.08 -2.21 Net Cash flow from Financing Activities -2.87 -2.40 6.08 -7.54 -3.95 Net Cash Flow -2.02 -1.95 10.16 3.62 -0.04 Closing Cash & Cash Equivalent 2.84 4.86 15.61 5.45 1.83 Closing Cash & Cash Equivalent Growth (%) -41.61 -68.84 186.33 197.41 -2.25 Total Debt/ CFO (x) 0.34 0.33 0.69 0.68 3.74 All figures in Rs Cr, unless mentioned otherwise
InsightsDecrease in Cash from Investing
Company has used Rs 20.3 cr for investing activities which is an YoY decrease of 2.03%. (Source: Consolidated Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) 18.62 22.60 29.13 44.11 18.02 Return on Capital Employed (%) 23.78 25.28 33.41 54.77 21.80 Return on Assets (%) 15.87 18.46 20.04 30.11 9.29 Interest Coverage Ratio (x) 30.79 42.18 32.76 26.80 5.19 Asset Turnover Ratio (x) 1.13 1.04 1.19 141.22 104.46 Price to Earnings (x) 17.57 6.55 7.54 5.06 4.99 Price to Book (x) 3.27 1.48 2.19 2.23 0.90 EV/EBITDA (x) 12.23 5.24 5.32 3.51 4.21 EBITDA Margin (%) 21.95 21.84 27.49 32.98 17.53
ADVERTISEMENT
Peer Comparison
NAME 1D 1W 1M 3M 1Y 3Y 5Y Titan Biotech Stock Performance 1.42 12.93 24.07 12.36 127.78 75.29 1503.41 Dharamsi Morarji Stock Performance -2.68 -2.66 2.09 7.38 23.98 -2.43 111.70 Sunshield Chem Stock Performance -0.08 17.98 41.84 19.42 56.83 275.00 539.66 Shree Pushkar Chem Stock Performance 0.47 23.36 24.29 18.28 8.16 16.85 62.30 Aarti Surfactants Stock Performance 0.90 3.76 3.22 7.33 10.23 -50.47 0.00 All values in %
Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 75.29% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)
Mutual Funds Ownership
No Data Available
ADVERTISEMENT
Corporate Actions
Final
20%
May 29, 2024
Board Meeting
Audited Results
May 21, 2024
Board Meeting
Quarterly Results
Jan 31, 2024
Announced on Ex-Date Dividend% Sep 06, 2023 Sep 22, 2023 18% Jun 01, 2022 Sep 22, 2022 15% Jul 01, 2021 Sep 16, 2021 15% Jun 30, 2020 Sep 17, 2020 10% May 29, 2024 - 20% No Data Available
No Data Available
No Data Available
Announced on Meeting on Sep 06, 2023 Sep 29, 2023 Rs.1.8000 per share(18%)Final Dividend & A.G.M. Aug 24, 2020 Sep 25, 2020 Book closure from 19 Sep, 2020 to 25 Sep, 2020 Sep 03, 2019 - Book closure from 24 Sep, 2019 to 30 Sep, 2019 Sep 03, 2019 - Book closure from 24 Sep, 2019 to 30 Sep, 2019 Sep 03, 2019 - Book closure from 24 Sep, 2019 to 30 Sep, 2019
ADVERTISEMENT
About
Titan Biotech Ltd., incorporated in the year 1992, is a Small Cap company (having a market cap of Rs 504.83 Crore) operating in Chemicals sector.
Titan Biotech Ltd. key Products/Revenue Segments include Biological Product for the year ending 31-Mar-2023.
For the quarter ended 31-03-2024, the company has reported a Consolidated Total Income of Rs 40.40 Crore, down 12.97 % from last quarter Total Income of Rs 46.42 Crore and up 8.22 % from last year same quarter Total Income of Rs 37.33 Crore. Company has reported net profit after tax of Rs 4.84 Crore in latest quarter.
The company’s top management includes Mr.Naresh Kumar Singla, Mr.Suresh Chand Singla, Mr.Raja Singla, Mr.Abhishek Agarwal, Mrs.Rekha Dalmia, Mr.Rohit Jain, Mrs.Manju Singla, Ms.Supriya Singla, Mr.Prem Shankar Gupta, Mr.Charanjit Singh. Company has Sunita Agrawal & Co. as its auditors. As on 31-03-2024, the company has a total of .83 Crore shares outstanding.
About Titan Biotech
Titan Biotech Ltd., incorporated in the year 1992, is a Small Cap company (having a market cap of Rs 504.83 Crore) operating in Chemicals sector. Titan Biotech Ltd. key Products/Revenue Segments include Biological Product for the year ending 31-Mar-2023.For the quarter ended 31-03-2024, the company has reported a Consolidated Total Income of Rs 40.40 Crore, down 12.97 % from last quarter Total Income of Rs 46.42 Crore and up 8.22 % from last year same quarter Total Income of Rs 37.33 Crore. Company has reported net profit after tax of Rs 4.84 Crore in latest quarter.The company’s top management includes Mr.Naresh Kumar Singla, Mr.Suresh Chand Singla, Mr.Raja Singla, Mr.Abhishek Agarwal, Mrs.Rekha Dalmia, Mr.Rohit Jain, Mrs.Manju Singla, Ms.Supriya Singla, Mr.Prem Shankar Gupta, Mr.Charanjit Singh. Company has Sunita Agrawal & Co. as its auditors. As on 31-03-2024, the company has a total of .83 Crore shares outstanding.
Industry
Key Indices Listed On
-
Address
A - 902 A, RIICO Industrial Area,Phase - III,Bhiwadi, Rajasthan - 301019
Executive Leadership
NK
Naresh Kumar Singla
Managing DirectorSC
Suresh Chand Singla
Managing DirectorRS
Raja Singla
Whole Time DirectorAA
Abhishek Agarwal
Independent DirectorShow More
Auditors
A N S K & Associates
Sunita Agrawal & Co.
FAQs about Titan Biotech share
- 1. What's the Titan Biotech share price today?Titan Biotech share price was Rs 610.90 as on 02 Jul, 2024, 03:56 PM IST. Titan Biotech share price was up by 1.42% based on previous share price of Rs 602.3. Titan Biotech share price trend:
- Last 1 Month: Titan Biotech share price moved up by 12.93%
- Last 3 Months: Titan Biotech share price moved up by 15.20%
- Last 12 Months: Titan Biotech share price moved up 131.18%
- Last 3 Years: Titan Biotech Share price moved up by 77.95%
- 2. What is the CAGR of Titan Biotech?The CAGR of Titan Biotech is 3.63.
- 3. Who are the peers for Titan Biotech in Chemicals sector?Within Chemicals sector Titan Biotech, Dai Ichi Karkaria Ltd., Aarti Surfactants Ltd., Chemcrux Enterprises Ltd., Shree Pushkar Chemicals & Fertilisers Ltd., Sunshield Chemicals Ltd., DMCC Speciality Chemicals Ltd., Alkali Metals Ltd., Lasa Supergenerics Ltd., Hardcastle & Waud Manufacturing Company Ltd. and Haryana Leather Chemicals Ltd. are usually compared together by investors for analysis.
- 4. What is the PE & PB ratio of Titan Biotech?The PE ratio of Titan Biotech stands at 20.31, while the PB ratio is 3.78.
- 5. What dividend is Titan Biotech giving?Titan Biotech Ltd. announced an equity dividend of 18% on a face value of 10.0 amounting to Rs 1.8 per share on 06 Sep 2023. The ex dividend date was 22 Sep 2023.
- 6. What are the returns for Titan Biotech share?Return Performance of Titan Biotech Shares:
- 1 Week: Titan Biotech share price moved up by 5.46%
- 1 Month: Titan Biotech share price moved up by 12.93%
- 3 Month: Titan Biotech share price moved up by 15.20%
- 6 Month: Titan Biotech share price moved up by 50.39%
- 7. What are the key metrics to analyse Titan Biotech Share Price?Key Metrics for Titan Biotech are:
- PE Ratio of Titan Biotech is 20.31
- Price/Sales ratio of Titan Biotech is 2.66
- Price to Book ratio of Titan Biotech is 3.74
- 8. What are the Titan Biotech quarterly results?On Consoldiated basis, Titan Biotech reported a total income and loss of Rs 40.40 Cr and Rs 5.00 respectively for quarter ending 2024-03-31. Total Income and profit for the year ending 2024-03-31 was Rs 165.82 Cr and Rs 24.85 Cr.
- 9. What is 52 week high/low of Titan Biotech share price?52 Week high of Titan Biotech share is Rs 645.00 while 52 week low is Rs 250.25
- 10. What is the market cap of Titan Biotech?Market Capitalization of Titan Biotech stock is Rs 504.83 Cr.
- 11. Who are the key owners of Titan Biotech stock?
- Promoter holding has not changed in last 9 months and holds 55.88 stake as on 31 Mar 2024
- Other investor holding have gone down from 44.12 (30 Jun 2023) to 43.89 (31 Mar 2024)
Trending in Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.